These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 23046997)

  • 1. Stem cells in severe infantile spinal muscular atrophy (SMA1).
    Carrozzi M; Amaddeo A; Biondi A; Zanus C; Monti F; Alessandro V
    Neuromuscul Disord; 2012 Nov; 22(11):1032-4. PubMed ID: 23046997
    [No Abstract]   [Full Text] [Related]  

  • 2. Stem cells in severe infantile spinal muscular atrophy (SMA1).
    Cohn RD
    Neuromuscul Disord; 2012 Dec; 22(12):1106-7. PubMed ID: 23206851
    [No Abstract]   [Full Text] [Related]  

  • 3. Stem cells in severe infantile spinal muscular atrophy (SMA1).
    Finkel RS
    Neuromuscul Disord; 2012 Dec; 22(12):1105-6. PubMed ID: 23206849
    [No Abstract]   [Full Text] [Related]  

  • 4. Stem cells in severe infantile spinal muscular atrophy.
    Mercuri E; Bertini E
    Neuromuscul Disord; 2012 Dec; 22(12):1105. PubMed ID: 23206850
    [No Abstract]   [Full Text] [Related]  

  • 5. Stem-cell ruling riles researchers.
    Abbott A
    Nature; 2013 Mar; 495(7442):418-9. PubMed ID: 23538801
    [No Abstract]   [Full Text] [Related]  

  • 6. The use of invasive ventilation is appropriate in children with genetically proven spinal muscular atrophy type 1: the motion against.
    Ryan MM
    Paediatr Respir Rev; 2008 Mar; 9(1):51-4; discussion 55-6. PubMed ID: 18280980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physician attitudes towards ventilatory support for spinal muscular atrophy type 1 in Australasia.
    Geevasinga N; Ryan MM
    J Paediatr Child Health; 2007 Dec; 43(12):790-4. PubMed ID: 17803671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcome measures in spinal muscular atrophy.
    Montes J; Gordon AM; Pandya S; De Vivo DC; Kaufmann P
    J Child Neurol; 2009 Aug; 24(8):968-78. PubMed ID: 19509409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allogeneic mesenchymal stem cell therapy outcomes for three patients with spinal muscular atrophy type 1.
    Villanova M; Bach JR
    Am J Phys Med Rehabil; 2015 May; 94(5):410-5. PubMed ID: 25882135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prenatal transplantation of human amniotic fluid stem cell could improve clinical outcome of type III spinal muscular atrophy in mice.
    Shaw SW; Peng SY; Liang CC; Lin TY; Cheng PJ; Hsieh TT; Chuang HY; De Coppi P; David AL
    Sci Rep; 2021 Apr; 11(1):9158. PubMed ID: 33911155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Global management of infantile spinal muscular atrophy. Practical guide for medical staff].
    Delmas MC; Bérard C
    Pediatrie; 1990; 45(7-8):457-64. PubMed ID: 2170920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transplanted ALDHhiSSClo neural stem cells generate motor neurons and delay disease progression of nmd mice, an animal model of SMARD1.
    Corti S; Locatelli F; Papadimitriou D; Donadoni C; Del Bo R; Crimi M; Bordoni A; Fortunato F; Strazzer S; Menozzi G; Salani S; Bresolin N; Comi GP
    Hum Mol Genet; 2006 Jan; 15(2):167-87. PubMed ID: 16339214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AVXS-101 (Onasemnogene Abeparvovec) for SMA1: Comparative Study with a Prospective Natural History Cohort.
    Al-Zaidy SA; Kolb SJ; Lowes L; Alfano LN; Shell R; Church KR; Nagendran S; Sproule DM; Feltner DE; Wells C; Ogrinc F; Menier M; L'Italien J; Arnold WD; Kissel JT; Kaspar BK; Mendell JR
    J Neuromuscul Dis; 2019; 6(3):307-317. PubMed ID: 31381526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spinal muscular atrophy with respiratory distress type 1 (SMARD1).
    Kaindl AM; Guenther UP; Rudnik-Schöneborn S; Varon R; Zerres K; Schuelke M; Hübner C; von Au K
    J Child Neurol; 2008 Feb; 23(2):199-204. PubMed ID: 18263757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parental role in the Intensive Care Unit for children affected by Werdnig Hoffmann disease.
    Ottonello G; Mastella C; Franceschi A; Lampugnani E; Moscatelli A; Punch F; Tumolo M; Penzo A; Gamba M; Bosticco D; Tuo P; Nahum L
    Minerva Pediatr; 2010 Apr; 62(2):147-51. PubMed ID: 20440234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distal infantile spinal muscular atrophy associated with paralysis of the diaphragm: a variant of infantile spinal muscular atrophy.
    Bertini E; Gadisseux JL; Palmieri G; Ricci E; Di Capua M; Ferriere G; Lyon G
    Am J Med Genet; 1989 Jul; 33(3):328-35. PubMed ID: 2801766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recommendations for the diagnosis and management of typical childhood spinal muscular atrophy.
    Cuisset JM; Estournet B;
    Rev Neurol (Paris); 2012 Dec; 168(12):902-9. PubMed ID: 23107878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infantile spinal muscular atrophy - the potential for cure of a fatal disease.
    Volpe JJ
    J Neonatal Perinatal Med; 2021; 14(2):153-157. PubMed ID: 33459670
    [No Abstract]   [Full Text] [Related]  

  • 19. Spinal muscular atrophy type 1: what are the ethics and practicality of respiratory support?
    Mitchell I
    Paediatr Respir Rev; 2006; 7 Suppl 1():S210-1. PubMed ID: 16798568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spinal muscular atrophy type 1: management and outcomes.
    Bach JR; Baird JS; Plosky D; Navado J; Weaver B
    Pediatr Pulmonol; 2002 Jul; 34(1):16-22. PubMed ID: 12112792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.